Medicine Tenders

The RFT closing date is 4pm 8 October 2026.

The tenderer must have returned a properly executed a deed of confidentiality to the afp in accordance with this rft and the tenderer holds all valid and satisfactory statement of tax record required for its entity type.

The afp has the absolute discretion to withhold, refuse or delay access to the rft documents where, in the afps opinion, the tenderers deed of confidentiality or other information provided by the tenderer is incomplete, insufficient, inaccurate, or otherwise gives rise to afp concerns regarding the suitability of granting access to the rft documents.

The supplier warrants that all representations, declarations, statements, information and documents made or provided by the supplier. . . are complete, accurate, uptodate and not misleading in any way. all representations, declarations, statements, information and documents made or provided by the supplier

The criteria against which the suppliers offer will be evaluated includes: clinical suitability of products, functionality of products, country of manufacture and active pharmaceutical ingredient origin product information for all products, comparative cost of offers, ability to meet the principals supply requirements including delivery lead times, the suppliers capability, experience and past performance, risk management strategies including emergency planning processes practices, etc and the suppliers commitment to economic, environmental, sustainable, and social objectives. The criteria against which the suppliers offer will be evaluated includes: clinical suitability of products, functionality of products, country of manufacture and active pharmaceutical ingredient origin product information for all products, comparative cost of offers, ability to meet the principals supply requirements including delivery lead times, the suppliers capability, experience and past performance, risk management strategies including emergency planning processes practices, etc and the suppliers commitment to economic, environmental, sustainable, and social objectives.

Mandatory requirements include compliance with insurance obligations, quality assurance QA as per ASNZS ISO ****: 2016 or licence to wholesale or therapeutic goods act **** Cth licence to manufacture, compliance with ethical supplier threshold and ethical supplier mandate, therapeutic goods act **** Cth certification for all products, coloured artwork and/or images for all products, and product packaging dimensions inner, outer and pallet including weight for all products. Mandatory requirements: compliance with pha insurance obligations yes no if no, update submitted document with response compliance with ethical supplier threshold and ethical supplier mandate relevant checks will be conducted by the principal compliance with pha quality assurance qa obligations yes no if no, update submitted document with response product packaging dimensions inner, outer and pallet including weight for all products yes no information to be completed within schedule 10 product list

The supplier must, on reasonable prior written notice from the principal, give the principal reasonable access to the suppliers premises and to supplier documentation, records and personnel, to enable the principal or a third party engaged by the principal to verify: the completeness and accuracy of information provided by the supplier in connection with the invitation process and the suppliers compliance with its obligations under these pha request for quote conditions. The supplier must, on reasonable prior written notice from the principal, give the principal reasonable access to the suppliers premises and to supplier documentation, records and personnel, to enable the principal or a third party engaged by the principal to verify: the completeness and accuracy of information provided by the supplier in connection with the invitation process and the suppliers compliance with its obligations under these pha request for quote conditions.

As part of its offer, the supplier must provide samples if requested of the goods offered in accordance with this clause. any goods supplied under a pha formed with the supplier must correspond with the sample submitted with the offer. As part of its offer, the supplier must provide samples if requested of the goods offered in accordance with this clause. any goods supplied under a pha formed with the supplier must correspond with the sample submitted with the offer.

Offers not meeting the mandatory requirements will be considered nonconforming. Offers not meeting the mandatory requirements will be considered nonconforming.

****

The supplier warrants that all representations, declarations, statements, information and documents made or provided by the supplier. . . are complete, accurate, uptodate and not misleading in any way. all representations, declarations, statements, information and documents made or provided by the supplier

The criteria against which the suppliers offer will be evaluated includes: clinical suitability of products, functionality of products, country of manufacture and active pharmaceutical ingredient origin product information for all products, comparative cost of offers, ability to meet the principals supply requirements including delivery lead times, the suppliers capability, experience and past performance, risk management strategies including emergency planning processes practices, etc and the suppliers commitment to economic, environmental, sustainable, and social objectives. The criteria against which the suppliers offer will be evaluated includes: clinical suitability of products, functionality of products, country of manufacture and active pharmaceutical ingredient origin product information for all products, comparative cost of offers, ability to meet the principals supply requirements including delivery lead times, the suppliers capability, experience and past performance, risk management strategies including emergency planning processes practices, etc and the suppliers commitment to economic, environmental, sustainable, and social objectives.

Mandatory requirements include compliance with insurance obligations, quality assurance QA as per ASNZS ISO ****: 2016 or licence to wholesale or therapeutic goods act **** Cth licence to manufacture, compliance with ethical supplier threshold and ethical supplier mandate, therapeutic goods act **** Cth certification for all products, coloured artwork and/or images for all products, and product packaging dimensions inner, outer and pallet including weight for all products. Mandatory requirements: compliance with pha insurance obligations yes no if no, update submitted document with response compliance with ethical supplier threshold and ethical supplier mandate relevant checks will be conducted by the principal compliance with pha quality assurance qa obligations yes no if no, update submitted document with response product packaging dimensions inner, outer and pallet including weight for all products yes no information to be completed within schedule 10 product list

The supplier must, on reasonable prior written notice from the principal, give the principal reasonable access to the suppliers premises and to supplier documentation, records and personnel, to enable the principal or a third party engaged by the principal to verify: the completeness and accuracy of information provided by the supplier in connection with the invitation process and the suppliers compliance with its obligations under these pha request for quote conditions. The supplier must, on reasonable prior written notice from the principal, give the principal reasonable access to the suppliers premises and to supplier documentation, records and personnel, to enable the principal or a third party engaged by the principal to verify: the completeness and accuracy of information provided by the supplier in connection with the invitation process and the suppliers compliance with its obligations under these pha request for quote conditions.

As part of its offer, the supplier must provide samples if requested of the goods offered in accordance with this clause. any goods supplied under a pha formed with the supplier must correspond with the sample submitted with the offer. As part of its offer, the supplier must provide samples if requested of the goods offered in accordance with this clause. any goods supplied under a pha formed with the supplier must correspond with the sample submitted with the offer.

Offers not meeting the mandatory requirements will be considered nonconforming. Offers not meeting the mandatory requirements will be considered nonconforming.

The estimated value is over 3m. infliximab estimated value over 3m